马方综合征患者主动脉夹层的支架辅助球囊诱导内膜撕裂与再层化:中期结局与主动脉重塑
该研究回顾了2015年至2017年11月接受支架辅助球囊诱导内膜撕裂与再层化治疗的7例马方综合征合并复杂性急性B型主动脉夹层患者,技术成功率100%,中位随访15个月,无全因死亡,所有患者治疗的胸腹主动脉完全重塑,但远端非支架段6例存在持续假腔血流。
要点
- 支架辅助球囊诱导内膜撕裂与再层化在马方综合征合并复杂性急性B型主动脉夹层中技术成功率为100%。
- 中位随访15个月,1例因Ia型内漏相关动脉瘤样退变需主动脉弓置换,晚期再干预率14%。
- 所有患者治疗的胸腹主动脉完全重塑,但远端非支架段6例有持续假腔血流,5例主髂动脉直径稳定。
核心结论
- 支架辅助球囊诱导内膜撕裂与再层化在马方综合征患者中可行、安全,并伴有即刻和中期持续的胸腹主动脉重塑。
研究设计与样本
- 回顾性分析2015年至2017年11月期间,7例根据修订版根特标准诊断为马方综合征并合并复杂性急性B型主动脉夹层的患者,接受支架辅助球囊诱导内膜撕裂与再层化治疗。
主要发现
- 患者中位年龄47岁(范围23-70岁),4例有主动脉根部置换史,技术成功率为100%。
- 3例需要辅助手术:肾动脉支架2例,髂动脉支架1例。
- 无院内死亡、术后30天卒中、脊髓缺血、缺血性结肠炎或需要透析的肾功能衰竭。
- 中位随访15个月(范围7-28个月),1例在2年时因Ia型内漏相关的动脉瘤样退变需要主动脉弓置换,晚期再干预率为14%。
- 无其他继发性内漏,主要内脏动脉通畅率为100%,无全因死亡报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to assess the midterm outcomes and aortic remodeling in patients with Marfan syndrome with complicated acute type B aortic dissection treated with stent-assisted, balloon-induced intimal disruption and relamination. METHODS: We reviewed all patients treated with stent-assisted, balloon-induced intimal disruption and relamination for a complicated acute type B aortic dissection associated with Marfan syndrome according to the revised Ghent criteria. RESULTS: Between 2015 and November 2017, 7 patients with Marfan syndrome underwent stent-assisted, balloon-induced intimal disruption and relamination for a complicated acute type B aortic dissection. The median age of patients was 47 years (range, 23-70). Four patients had a history of aortic root replacement. Technical success was achieved in 100%. Three patients required an adjunctive procedure for renal artery stenting (n = 2) and iliac artery stenting (n = 1). There was no in-hospital death, 30-day postoperative stroke, spinal cord ischemia, ischemic colitis, or renal failure requiring dialysis. At a median follow-up of 15 months (range, 7-28), 1 patient required aortic arch replacement for aneurysmal degeneration associated with a type Ia endoleak at 2 years, giving a late reintervention rate of 14%. There was no other secondary endoleak. The primary visceral patency rate was 100%. There were no all-cause deaths reported. At last computed tomography scan, all patients had complete aortic remodeling of the treated thoracoabdominal aorta. Distally, at the nonstented infrarenal aortoiliac level, 6 patients had persistent false lumen flow with stable aorto-iliac diameter in 5. One patient had iliac diameter growth (27 mm diameter at last computed tomography scan). CONCLUSIONS: Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection in patients with Marfan syndrome is feasible, safe, and associated with an immediate and midterm persisting thoracoabdominal aortic remodeling.
引用
- Faure EM, El Batti S, Abou Rjeili M, et al. Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection in patients with Marfan syndrome: Midterm outcomes and aortic remodeling. J Thorac Cardiovasc Surg. 2018. PMID: 29934004. doi:10.1016/j.jtcvs.2018.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。